Brian M. Stolz, EVP, Administration and CHCO at Valeant Pharmaceuticals International, Inc. (VRX), bought 2,680 shares at $41.00 ($110K) on 2011-08-26, disclosed to the SEC on 2011-08-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| VRX | BUY | 2012-11-08 | $108K | — | Filing → |
| VRX | BUY | 2012-05-14 | $266K | — | Filing → |
| VRX | BUY | 2011-11-18 | $101K | — | Filing → |